SELECT: A multicenter phase II trial of adjuvant erlotinib in resected early-stage EGFR mutation-positive NSCLC Meeting Abstract
| Authors: | Pennell, N. A.; Neal, J. W.; Chaft, J. E.; Azzoli, C. G.; Jänne, P. A.; Govindan, R.; Evans, T. L.; Costa, D. B.; Rosovsky, R. P. G.; Wakelee, H. A.; Heist, R. S.; Shaw, A. T.; Temel, J. S.; Shapiro, M. A.; Muzikansky, A.; Lanuti, M.; Lynch, T. J.; Kris, M. G.; Sequist, L. V. |
| Abstract Title: | SELECT: A multicenter phase II trial of adjuvant erlotinib in resected early-stage EGFR mutation-positive NSCLC |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203950 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.7514 |
| Notes: | Meeting Abstract: 7514 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
